Showing results (541-550 of 7,006) with videos related to

Sort By:
Pageof 701
Lung Cancer (Amsterdam, Netherlands)|August 10, 2018
Genetic and clinicopathologic characteristics of lung adenocarcinoma with tumor spread through air spacesJae Seok Lee, Eun Kyung Kim, Moonsik Kim, et al.
Lung Cancer (Amsterdam, Netherlands)|August 10, 2018
An updated and validated PET/CT volumetric prognostic index for non-small cell lung cancerJoshua H Finkle, Bill C Penney, Yonglin Pu
Lung Cancer (Amsterdam, Netherlands)|August 10, 2018
Inhibition of IGF1R enhances 2-deoxyglucose in the treatment of non-small cell lung cancerFakeng Liu, Yuan Liu, Xiuju Liu, et al.
Lung Cancer (Amsterdam, Netherlands)|August 10, 2018
Next generation sequencing reveals a novel ALK G1128A mutation resistant to crizotinib in an ALK-Rearranged NSCLC patientXinghao Ai, Xiaomin Niu, Lianpeng Chang, et al.
Lung Cancer (Amsterdam, Netherlands)|April 17, 2018
Nivolumab-induced severe pancytopenia in a patient with lung adenocarcinomaKentaro Tokumo, Takeshi Masuda, Takahiko Miyama, et al.
Lung Cancer (Amsterdam, Netherlands)|April 17, 2018
Tumor associated macrophages support the growth of FGF9-induced lung adenocarcinoma by multiple mechanismsAhmed E Hegab, Mari Ozaki, Shizuko Kagawa, et al.
Lung Cancer (Amsterdam, Netherlands)|April 17, 2018
Afatinib in heavily pretreated advanced NSCLC patients who progressed following prior gefitinib or erlotinib: Compassionate use program in KoreaMoon Ki Choi, Jin Seok Ahn, Young-Chul Kim, et al.
Lung Cancer (Amsterdam, Netherlands)|April 17, 2018
Extraction of radiomic values from lung adenocarcinoma with near-pure subtypes in the International Association for the Study of Lung Cancer/the American Thoracic Society/the European Respiratory Society (IASLC/ATS/ERS) classificationShun-Mao Yang, Li-Wei Chen, Hao-Jen Wang, et al.
Lung Cancer (Amsterdam, Netherlands)|April 17, 2018
Feasibility of endobronchial ultrasound transbronchial needle aspiration for massively parallel next-generation sequencing in thoracic cancer patientsSimon R Turner, Darren Buonocore, Patrice Desmeules, et al.
Lung Cancer (Amsterdam, Netherlands)|September 7, 2016
A phase 2 randomized study of TAS-102 versus topotecan or amrubicin in patients requiring second-line chemotherapy for small cell lung cancer refractory or sensitive to frontline platinum-based chemotherapyGiorgio Scagliotti, Makoto Nishio, Miyako Satouchi, et al.
Pageof 701